SLC3A2 and Alzheimer disease: Among the detected markers, 4 were differentially abundant in AD CAA(+) vessels (PTGDS, BSG, SLC3A2, SLC7A5; Fig. 3c–f) and the same was observed in MCI except with no change in SLC3A2.